[
  {
    "ts": null,
    "headline": "Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica",
    "summary": "Single-use bioprocessing offers transformative potential, unlocked by new 6,000 L commercial scalability and 50% CAPEX reductions. With superior sustainability profiles and proven regulatory success, it is now the definitive standard for agile, high-margin commercial manufacturing globally.Chicago, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The global single-use bioprocessing market reached a valuation of USD 30.12 billion in 2025 and is forecasted to expand to USD 122.92 billion by 2035, achieving a rob",
    "url": "https://finnhub.io/api/news?id=8487fd01d04057a7ba97bf7c6ef95cf59bbb8b13e036c68188e32cd08bfb96b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768930680,
      "headline": "Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica",
      "id": 138188519,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Single-use bioprocessing offers transformative potential, unlocked by new 6,000 L commercial scalability and 50% CAPEX reductions. With superior sustainability profiles and proven regulatory success, it is now the definitive standard for agile, high-margin commercial manufacturing globally.Chicago, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The global single-use bioprocessing market reached a valuation of USD 30.12 billion in 2025 and is forecasted to expand to USD 122.92 billion by 2035, achieving a rob",
      "url": "https://finnhub.io/api/news?id=8487fd01d04057a7ba97bf7c6ef95cf59bbb8b13e036c68188e32cd08bfb96b2"
    }
  },
  {
    "ts": null,
    "headline": "CURE: Benefits And Caveats Of The Leveraged Healthcare ETF",
    "summary": "Direxion CURE ETF offers 3x daily healthcare exposureâlearn risks like volatility decay and drift, plus tactical trading tips using XLV/index signals.",
    "url": "https://finnhub.io/api/news?id=ca3612c5b4891b901620bb4fdb6c38f001242d9ac0824dccbf1890b2577a24b9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768912790,
      "headline": "CURE: Benefits And Caveats Of The Leveraged Healthcare ETF",
      "id": 138188296,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1351287260/image_1351287260.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Direxion CURE ETF offers 3x daily healthcare exposureâlearn risks like volatility decay and drift, plus tactical trading tips using XLV/index signals.",
      "url": "https://finnhub.io/api/news?id=ca3612c5b4891b901620bb4fdb6c38f001242d9ac0824dccbf1890b2577a24b9"
    }
  },
  {
    "ts": null,
    "headline": "How Investors May Respond To NVIDIA (NVDA) Expanding Its AI Platform From Gaming To Drug Discovery",
    "summary": "NVIDIA and its partners have, over recent days, unveiled a wave of new AI hardware and collaborations, from Blackwell-based GeForce RTX 5090 gaming cards and Vera Rubin data center systems to deep-life-sciences tie‑ups with Eli Lilly, Natera, Thermo Fisher and others built on the NVIDIA AI platform. Together, these launches and alliances extend NVIDIA’s AI reach from gaming and autonomous vehicles to drug discovery, industrial automation and privacy-first cloud infrastructure, reinforcing...",
    "url": "https://finnhub.io/api/news?id=4242df3b587e1f1967ec463f3f2233e8d06913f6830267c6b88bf125a941e17d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768889451,
      "headline": "How Investors May Respond To NVIDIA (NVDA) Expanding Its AI Platform From Gaming To Drug Discovery",
      "id": 138184341,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "NVIDIA and its partners have, over recent days, unveiled a wave of new AI hardware and collaborations, from Blackwell-based GeForce RTX 5090 gaming cards and Vera Rubin data center systems to deep-life-sciences tie‑ups with Eli Lilly, Natera, Thermo Fisher and others built on the NVIDIA AI platform. Together, these launches and alliances extend NVIDIA’s AI reach from gaming and autonomous vehicles to drug discovery, industrial automation and privacy-first cloud infrastructure, reinforcing...",
      "url": "https://finnhub.io/api/news?id=4242df3b587e1f1967ec463f3f2233e8d06913f6830267c6b88bf125a941e17d"
    }
  },
  {
    "ts": null,
    "headline": "1 Mooning  Stock to Own for Decades and 2 We Question",
    "summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
    "url": "https://finnhub.io/api/news?id=24f7e721de4ebee19aff25a40001fd9dd5b5812096fb859a4d4dc6c1538370f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768883822,
      "headline": "1 Mooning  Stock to Own for Decades and 2 We Question",
      "id": 138185031,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
      "url": "https://finnhub.io/api/news?id=24f7e721de4ebee19aff25a40001fd9dd5b5812096fb859a4d4dc6c1538370f9"
    }
  }
]